Summit Therapeutics PLC (SMMT)
Summit Therapeutics PLC (SMMT) is a NASDAQ-listed ADR, or depositary receipt, tied to the company’s underlying shares rather than an operating business of its own. The security reflects Summit Therapeutics PLC, which is classified in healthcare and biotechnology. In broad terms, the company is associated with drug development work, including research-stage and clinical-stage programs in therapeutic areas such as oncology. Because this is an ADR, investors are looking at a listed instrument that tracks the foreign issuer’s equity interest, not a separate product company. The classification details indicate a common stock depositary receipt on NASDAQ.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-SMMT
|
$15.32
|
-1.0% Downside
|
Fair
|
$30.28
|
95.8% Upside
|
Bargain
|
Fair
|
0.0%
|
November 11, 2026
|
19.6x
|
12.372 B
|
11.701 B
|
0.2%
|
19.3%
|
52.8
|
53.7%
|
